Related references
Note: Only part of the references are listed.Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets
Z. M. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Integration of signals generated by nutrients, hormones, and exercise in skeletal muscle
Scot R. Kimball
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
P. Loria et al.
ATHEROSCLEROSIS (2014)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
CIRCULATION (2014)
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
H. Kahal et al.
CLINICAL ENDOCRINOLOGY (2014)
Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease
Meropi D. Kontogianni et al.
CLINICAL NUTRITION (2014)
The Role of Medications for the Management of Patients with NAFLD
Natalia Mazzella et al.
CLINICS IN LIVER DISEASE (2014)
Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis
Hye Duck Choi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
Yumie Takeshita et al.
DIABETOLOGIA (2014)
Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial
J. de Jager et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Chemopreventive strategies in hepatocellular carcinoma
Siddharth Singh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Irisin in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Glucose-Induced Glucagon-Like Peptide 1 Secretion Is Deficient in Patients with Non-Alcoholic Fatty Liver Disease
Christine Bernsmeier et al.
PLOS ONE (2014)
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
Stefano Ballestri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
M. J. Armstrong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease
Susan S. Cho et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
E. Scorletti et al.
Annual Review of Nutrition (2013)
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
Ebenezer T. Oni et al.
ATHEROSCLEROSIS (2013)
The cardiovascular safety of incretin-based therapies: a review of the evidence
John R. Petrie
CARDIOVASCULAR DIABETOLOGY (2013)
Is mipomersen ready for clinical implementation? A transatlantic dilemma
Barbara Sjouke et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
Amedeo Lonardo et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Statins and primary liver cancer: a meta-analysis of observational studies
Danitza Pradelli et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Statin use and risk of hepatocellular carcinoma
Shih-Wei Lai et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2013)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Both Resistance Training and Aerobic Training Reduce Hepatic Fat Content in Type 2 Diabetic Subjects With Nonalcoholic Fatty Liver Disease (the RAED2 Randomized Trial)
Elisabetta Bacchi et al.
HEPATOLOGY (2013)
Dietary fructose in nonalcoholic fatty liver disease
Miriam B. Vos et al.
HEPATOLOGY (2013)
Liver and diabetes. A vicious circle
Paola Loria et al.
HEPATOLOGY RESEARCH (2013)
Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus
Daisuke Suzuki et al.
INTERNAL MEDICINE (2013)
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
Matti J. Tikkanen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Barbara Fruci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Antioxidant Supplements to Prevent Mortality
Goran Bjelakovic et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Improved Hepatic Lipid Composition Following Short-Term Exercise in Nonalcoholic Fatty Liver Disease
Jacob M. Haus et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis
Yosui Tamaki et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Diet and exercise in management of obesity and overweight
Kwong Ming Fock et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
Marno C. Ryan et al.
JOURNAL OF HEPATOLOGY (2013)
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients
Salvatore Petta et al.
JOURNAL OF HEPATOLOGY (2013)
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
Derrick M. Van Rooyen et al.
JOURNAL OF HEPATOLOGY (2013)
From NAFLD in clinical practice to answers from guidelines
Fabio Nascimbeni et al.
JOURNAL OF HEPATOLOGY (2013)
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Shin Yoshimoto et al.
NATURE (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Pharmacological agents for NASH
Vlad Ratziu
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats
Selvihan Beysel Akaslan et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2013)
Nonalcoholic Fatty Liver Disease and Reduced Serum Vitamin D3 Levels
Giovanni Targher et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2013)
The Cardiovascular Safety of Diabetes Drugs - Insights from the Rosiglitazone Experience
William R. Hiatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
Maria Carla Roncaglioni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
被撤回的出版物: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet (Retracted article. See vol. 378, pg. 2441, 2018)
Ramon Estruch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Multi-Centre European Experience with Intragastric Balloon in Overweight Populations: 13 Years of Experience
Alfredo Genco et al.
OBESITY SURGERY (2013)
Five Percent Weight Lost in the First Month of Intragastric Balloon Treatment May Be a Predictor for Long-Term Weight Maintenance
Umit Bilge Dogan et al.
OBESITY SURGERY (2013)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
Hui Zhang et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Diagnosis and Management of Nonalcoholic Fatty Liver Disease and Its Hemostatic/Thrombotic and Vascular Complications
Giovanni Targher et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
Takumi Hirata et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
Beth A. Conlon et al.
NUTRIENTS (2013)
When to remeasure cardiovascular risk in untreated people at low and intermediate risk: observational study
Katy J. L. Bell et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Bariatric Surgery as Potential Treatment for Nonalcoholic Fatty Liver Disease: A Future Treatment by Choice or by Chance?
Shuja Hafeez et al.
JOURNAL OF OBESITY (2013)
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
E. Boettcher et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study
L. Gerber et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
Helena Bjermo et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
James L. Trevaskis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Metformin and its clinical use: new insights for an old drug in clinical practice
Arrigo F. G. Cicero et al.
ARCHIVES OF MEDICAL SCIENCE (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Joep Perk Chairperson et al.
ATHEROSCLEROSIS (2012)
Fish oil - How does it reduce plasma triglycerides?
Gregory C. Shearer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
Kavita Bhalla et al.
CANCER PREVENTION RESEARCH (2012)
Improving dietary patterns in patients with nonalcoholic fatty liver disease
Sofia Carvalhana et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2012)
Effects of Physical Exercise on Inflammatory Markers of Atherosclerosis
A. Pinto et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
Dhanwantee Mundil et al.
DIABETES & VASCULAR DISEASE RESEARCH (2012)
Liver Fat Is Reduced by an Isoenergetic MUFA Diet in a Controlled Randomized Study in Type 2 Diabetic Patients
Lutgarda Bozzetto et al.
DIABETES CARE (2012)
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
Ping Wang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
A. Neumann et al.
DIABETOLOGIA (2012)
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso et al.
DIABETOLOGIA (2012)
If steatosis is the atherosclerosis of the liver, are statins the aspirin for steatosis?
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2012)
Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
Hideyuki Hyogo et al.
DIGESTIVE AND LIVER DISEASE (2012)
Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial
Maartje E. Visser et al.
EUROPEAN HEART JOURNAL (2012)
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis
Roberto Fogari et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
Yin-Mei Lee et al.
GASTROINTESTINAL ENDOSCOPY (2012)
Bariatric surgery and cardiovascular outcomes: a systematic review
Amanda R. Vest et al.
HEART (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Bariatric Surgery and Long-term Cardiovascular Events
Lars Sjostrom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Potential for statins in the chemoprevention and management of hepatocellular carcinoma
Amedeo Lonardo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Shelley E. Keating et al.
JOURNAL OF HEPATOLOGY (2012)
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Helen M. Parker et al.
JOURNAL OF HEPATOLOGY (2012)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
Christian Thoma et al.
JOURNAL OF HEPATOLOGY (2012)
The Framingham risk score and heart disease in nonalcoholic fatty liver disease
Sombat Treeprasertsuk et al.
LIVER INTERNATIONAL (2012)
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD
Stefano Ballestri et al.
LIVER INTERNATIONAL (2012)
Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects
Lena M. S. Carlsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The renin-angiotensin system: a link between obesity, inflammation and insulin resistance
N. S. Kalupahana et al.
OBESITY REVIEWS (2012)
Intragastric Balloon in Association with Lifestyle and/or Pharmacotherapy in the Long-Term Management of Obesity
Maria Grazia Farina et al.
OBESITY SURGERY (2012)
500 Intragastric Balloons: What Happens 5 Years Thereafter?
Katerina Kotzampassi et al.
OBESITY SURGERY (2012)
Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
Matthias Kern et al.
PLOS ONE (2012)
Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Daniel J. Cuthbertson et al.
PLOS ONE (2012)
The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
Takamasa Ohki et al.
SCIENTIFIC WORLD JOURNAL (2012)
Alcohol consumption appears to protect against non-alcoholic fatty liver disease
A. Moriya et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease
Kristin D. Kistler et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
Vasilios G. Athyros et al.
ANNALS OF MEDICINE (2011)
Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease
Silvia Sookoian et al.
ATHEROSCLEROSIS (2011)
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Alberico L. Catapano et al.
ATHEROSCLEROSIS (2011)
Polymorphism in the Farnesyl Diphosphate Farnesyl Transferase 1 Gene and Nonalcoholic Fatty Liver Disease Severity
Stefano Ballestri et al.
GASTROENTEROLOGY (2011)
Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
Derrick M. van Rooyen et al.
GASTROENTEROLOGY (2011)
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
Kate Hallsworth et al.
GUT (2011)
Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
Tomoyuki Iwasaki et al.
HEPATO-GASTROENTEROLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Hyohun Park et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period
Ayaka Hamabe et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
Claudia O. Zein et al.
JOURNAL OF HEPATOLOGY (2011)
Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
Elena Sofer et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Effects of Combined Exenatide and Pioglitazone Therapy on Hepatic Fat Content in Type 2 Diabetes
Padma Sathyanarayana et al.
OBESITY (2011)
GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
Shvetank Sharma et al.
PLOS ONE (2011)
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
E. J. Mills et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?
Amedeo Lonardo et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series
Patrick R. Kenny et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations
Sebastien Czernichow et al.
BRITISH JOURNAL OF NUTRITION (2010)
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Philip Greenland et al.
CIRCULATION (2010)
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
Dick C. Chan et al.
DIABETES CARE (2010)
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee
P. Loria et al.
DIGESTIVE AND LIVER DISEASE (2010)
Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up
Cecilia Soderberg et al.
HEPATOLOGY (2010)
Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has a Direct Role in Decreasing Hepatic Steatosis In Vitro by Modulating Elements of the Insulin Signaling Pathway
Nitika Arora Gupta et al.
HEPATOLOGY (2010)
Fitness Versus Fatness: Moving Beyond Weight Loss in Nonalcoholic Fatty Liver Disease
Nathan A. Johnson et al.
HEPATOLOGY (2010)
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
HEPATOLOGY (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma
Rossana M. Calderon et al.
MAYO CLINIC PROCEEDINGS (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Omega-3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review
Paul E. Marik et al.
CLINICAL CARDIOLOGY (2009)
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Nila Rafiq et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Exenatide: clinical aspects of the first incretin-mimetic for the treatment of type 2 diabetes mellitus
Estela Wajcberg et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
Andrea J. Cussons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue
Hiroshi Kudo et al.
LIVER INTERNATIONAL (2009)
Endocrine and liver interaction: the role of endocrine pathways in NASH
Paola Loria et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
Eugen Florin Georgescu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Rajasekhara R. Mummadi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Ls liver fat detrimental to vessels? intersections in the pathogenesis of NAFLD and atherosclerosis
Paola Loria et al.
CLINICAL SCIENCE (2008)
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
David C. Klonoff et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
Winston Dunn et al.
HEPATOLOGY (2008)
Statins in liver disease: A molehill, an iceberg, or neither?
Curtis K. Argo et al.
HEPATOLOGY (2008)
Safety and effectiveness of the intragastric balloon for obesity.: A meta-analysis
Inaki Imaz et al.
OBESITY SURGERY (2008)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
Glen Lutchman et al.
HEPATOLOGY (2007)
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
Giovanni Targher et al.
DIABETES CARE (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Prediction of first coronary events with the Framingham score: A systematic review
Klaus Eichler et al.
AMERICAN HEART JOURNAL (2007)
Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials)
Richard Andraws et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
How different is the dietary pattern in non-alcoholic steatohepatitis patients?
H. Cortez-Pinto et al.
CLINICAL NUTRITION (2006)
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
XK Ding et al.
HEPATOLOGY (2006)
Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study
JM Dekker et al.
CIRCULATION (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation
M Ferrario et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2005)
Long term prognosis of fatty liver: risk of chronic liver disease and death
S Dam-Larsen et al.
GUT (2004)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Electron beam CT versus helical CT scans for assessing coronary calcification: Current utility and future directions
K Nasir et al.
AMERICAN HEART JOURNAL (2003)
Share Paper
